Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8883849 | GLAXOSMITHKLINE | Treatment of sleep disturbances |
Jan, 2022
(1 year, 2 months ago) | |
US9155718 | GLAXOSMITHKLINE | Treatment of sleep disturbances |
Jan, 2022
(1 year, 2 months ago) |
Market Authorisation Date: 21 December, 2005
Treatment: A method of treating a patient suffering from a pain associated sleep disturbance comprising administering a liquid composition formulated inside a soft gel capsule, as claimed, to the patient
Dosage: CAPSULE;ORAL
6
United States
2
Japan
1
Germany
1
Hong Kong
1
Denmark
1
Austria
1
Mexico
1
Spain
1
Canada
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic